Association of the tumor necrosis factor-alpha −308 G/A polymorphism with nasal polyposis

Nasal polyposis (NP) is a chronic inflammatory disease in which several molecular and cellular interactions play important roles. Tumor necrosis factor-alpha (TNF-α) is a major pro-inflammatory cytokine with a key role in immune inflammatory responses in NP. Altered levels of TNF-α, which may occur due to polymorphisms in the TNF-α promoter region, may also be associated with NP susceptibility. Given these facts, we investigated the possible association of the TNF-α −308 G/A single nucleotide polymorphism (SNP) with NP. In this study, 97 consecutive adult patients with NP and 95 age- and gender-matched controls were recruited. For identification of SNP, restriction fragment length polymorphism analysis after polymerase chain reaction was carried out. The NP group had a significantly higher rate of polymorphism compared to controls (p = 0.015). Logistic regression analysis revealed that the presence of the TNF-α −308 G/A SNP is an independent risk factor for NP development (OR, 3.68; CI, 1.27–10.7; p = 0.016). The presence of a mutation failed to influence disease severity on the basis of resistance to medical and/or surgical treatment. This study suggests a possible linkage of a SNP in the TNF-α promoter with NP. These results need to be confirmed with multicentre studies for more precise interpretation and corroborative studies for investigating the influence of polymorphism on transcriptional activity.